Latest Interim Results News

The a2 Milk Company has reported robust half-year results with strong revenue and earnings growth, driven by gains in infant formula and liquid milk segments, alongside a strategic supply chain transformation. The company has upgraded its full-year outlook and announced a substantial special dividend, signalling confidence in its growth trajectory.

Pro Medicus Limited has reported a stellar half-year performance with revenue up 28.4% and a surge in net profit, driven by major US contract wins and strategic investments.

Tamawood Limited has reported a robust interim financial performance for the half year ended December 2025, showcasing significant growth in revenue, profit, and net tangible assets per share. The company’s reinstated dividend reinvestment plan and upcoming dividend review add to investor interest.

WAM Strategic Value Limited has delivered a robust 9.8% portfolio gain in H1 2025, outperforming the ASX index and announcing a 200% increase in operating profit alongside a higher fully franked interim dividend.

Humm Group Limited reported a $13.9 million statutory profit for the half-year ended December 2025, despite increased credit losses and elevated costs. The company’s ongoing transformation and global expansion underpin cautious optimism for the year ahead.

Treasury Wine Estates has resolved its dispute with US distributor RNDC following RNDC’s exit from California, with a settlement impacting cash flow but supporting a positive earnings outlook for the first half of 2026.

Bailador Technology Investments reports a 33% rise in net profit for HY26 and declares a fully-franked interim dividend, underpinned by robust portfolio company valuations and cash realisations.

Garda Property Group reported a 16% rise in revenue and a 20% increase in funds from operations for the first half of 2026, while net profit after tax fell by nearly 24%. The group declared a steady interim distribution of 4 cents per security.

Orbminco Limited reports promising interim infill drilling results at its Majestic North Gold Project, confirming high-grade shallow gold zones and potential southern extensions. The company also secures $5 million in a two-tranche placement to accelerate resource delineation and development.

Pinnacle Investment Management reported a solid 13% increase in funds under management to $202.5 billion despite an 11% drop in half-year profit. The company declared a 29 cent interim dividend and advanced its international expansion with key acquisitions.

Pinnacle Investment Management reported a robust 66.6% increase in revenues for the half year ended December 2025, yet profits and earnings per share declined, prompting a cautious outlook despite a healthy interim dividend.

Actinogen Medical has raised approximately $17 million through a share placement and purchase plan to fund the completion of its pivotal XanaMIA Alzheimer’s trial following encouraging interim results.